CAS: 145195-63-7; (Z)-Entacapone

结构式图片

相似化合物

130929-57-6 857629-79-9 1364322-41-7

上下游产品

CAS号26391-06-0 N,N-二乙基氰乙酰胺 | CAS号116313-85-0 3,4-二羟基-5-硝基苯甲醛 | CAS号146698-91-1 (E/Z)-3-O-Methy... | CAS号686349-59-7 entacapone | CAS号130929-57-6 恩他卡朋

合成工艺路线路线简述

    📜Entacapone 以 甲苯 用作溶剂,化学反应 4.0H,反应生成(2Z)-2-氰基-3-(3,4-二羟基-5-硝基苯基)-N,N-二乙基-2-丙烯酰胺
    参考文献:Wo2007/94007
    标题:Wo2007/94007

    海关参考信息

    专利信息


    专利号:WO-2008098960-A1
    优先权日:2007-02-13
    标 题:Process for preparing entacapone substantially free of z-isomer, synthesis intermediates thereof and a new crystalline form

    专利号:US-2009326062-A1
    优先权日:2007-02-13
    标 题 :Process for preparing entacapone substantially free of z-isomer, synthesis intermediates thereof and a new crystalline form

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    1. Wikberg, T., Vuorela, A., Ottoila, P., et al. Identification of major metabolites of the catechol-O-methyltransferase inhibitor entacapone in rats and humans. Drug Metab. Dispos. 21(1), 81-92 (1993). 2. Tekale, P., Tekale, S., and Mhatre, V.S. Determination of impurities in formulated form of entacapone by RP-HPLC method. Der Pharma Chemica 3(5), 63-68 (2011). 3. Soukhova, N.S., Kassymbek, Z., Bradby, S., et al. Development of characterization methods for entacapone in a pharmaceutical bulk. J. Pharm. Biomed. Anal. 54(4), 860-865 (2011).

    合成参考文献


    摘要:S113 | SWISSPHARMA24 | 2024 Swiss Pharmaceutical List with Metabolites | DOI:10.5281/zenodo.10501043
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知